Single Point Partners, LLC Pfizer Inc Transaction History

Single Point Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$32.09 - $37.51 $226,780 - $265,083	7,067 New	7,067 $234,000
Q1 2023 Apr 06, 2023	BUY	$39.39 - $51.28 $24,500 - $31,896	622 Added 4.79%	13,617 $556,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $18,495 - $24,143	-443 Reduced 3.3%	12,995 $666,000
Q3 2022 Oct 07, 2022	SELL	$43.76 - $53.42 $20,873 - $25,481	-477 Reduced 3.43%	13,438 $588,000
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $173,277 - $205,453	3,724 Added 36.54%	13,915 $730,000
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $16,378 - $20,295	-358 Reduced 3.39%	10,191 $528,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $435,884 - $646,126	10,549 New	10,549 $623,000
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $543,612 - $698,317	-13,850 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $6,499 - $7,363	-181 Reduced 1.29%	13,850 $542,000
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $145,045 - $163,581	4,331 Added 44.65%	14,031 $509,000
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $137,762 - $175,176	-4,116 Reduced 29.79%	9,700 $357,000
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $13,271 - $15,570	-418 Reduced 2.94%	13,816 $507,000
Q2 2020 Jul 30, 2020	SELL	$30.12 - $36.54 $58,312 - $70,741	-1,936 Reduced 11.97%	14,234 $465,000
Q1 2020 Apr 17, 2020	SELL	$27.03 - $38.62 $3,027 - $4,325	-112 Reduced 0.69%	16,170 $528,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $536,003 - $608,295	16,282 New	16,282 $638,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Single Point Partners, LLC with notifications on news.